Literature DB >> 2726839

Recent advances in comparative molecular field analysis (CoMFA).

R D Cramer1, D E Patterson, J D Bunce.   

Abstract

Comparative Molecular Field Analysis (CoMFA) has shown predictive performance and versatility that appear to be unprecedented among computer-based techniques for aiding molecular design.

Mesh：

Substances：

Year:  1989        PMID： 2726839

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


  33 in total

1.  High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors.

Authors:  R E Wilcox; J E Ragan; R S Pearlman; M Y Brusniak; R M Eglen; D W Bonhaus; T E Tenner; J D Miller
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

2.  3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.

Authors:  Elena Cichero; Laura Buffa; Paola Fossa
Journal:  J Mol Model       Date:  2010-10-05       Impact factor: 1.810

3.  CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.

Authors:  Elena Cichero; Sara Cesarini; Luisa Mosti; Paola Fossa
Journal:  J Mol Model       Date:  2010-02-20       Impact factor: 1.810

4.  Efficient overlay of small organic molecules using 3D pharmacophores.

Authors:  Gerhard Wolber; Alois A Dornhofer; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2006-10-19       Impact factor: 3.686

5.  Localization of ligand binding site in proteins identified in silico.

Authors:  Michal Brylinski; Marek Kochanczyk; Elzbieta Broniatowska; Irena Roterman
Journal:  J Mol Model       Date:  2007-03-30       Impact factor: 1.810

6.  Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.

Authors:  Elena Cichero; Sara Cesarini; Andrea Spallarossa; Luisa Mosti; Paola Fossa
Journal:  J Mol Model       Date:  2008-12-09       Impact factor: 1.810

7.  Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.

Authors:  Elena Cichero; Sara Cesarini; Andrea Spallarossa; Luisa Mosti; Paola Fossa
Journal:  J Mol Model       Date:  2009-01-20       Impact factor: 1.810

8.  Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.

Authors:  Atul T Manvar; Raghuvir R S Pissurlenkar; Vijay R Virsodia; Kuldip D Upadhyay; Dinesh R Manvar; Arun K Mishra; Hrishikesh D Acharya; Alpesh R Parecha; Chintan D Dholakia; Anamik K Shah; Evans C Coutinho
Journal:  Mol Divers       Date:  2009-06-24       Impact factor: 2.943

9.  2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.

Authors:  Joseph Rebehmed; Florent Barbault; Cátia Teixeira; François Maurel
Journal:  J Comput Aided Mol Des       Date:  2008-05-28       Impact factor: 3.686

10.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.